Related Experiment Video
Updated: Dec 26, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities
Anika Himmelsbach1, Carina Ciliox1, Claudia Goettsch1
1Department of Internal Medicine I, Cardiology, Medical Faculty, RWTH, Aachen University, 52074 Aachen, Germany.
Insights
New therapies and biomarkers show promise for treating cardiovascular calcification in chronic kidney disease (CKD) patients. Early detection and intervention are crucial for reducing cardiovascular risk in this vulnerable population.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Patients with chronic kidney disease (CKD) face a high risk of cardiovascular (CV) complications, including heart failure and stroke.
- Cardiovascular calcification significantly elevates CV risk in CKD patients, yet effective treatments and early diagnostic biomarkers are lacking.
- The asymptomatic nature of calcification progression and limited high-resolution imaging hinder early detection and intervention.
Purpose of the Study:
- To review and evaluate the latest advancements in therapeutic interventions and diagnostic markers for cardiovascular calcification in CKD.
- To analyze the potential of novel treatments and biomarkers in managing and preventing CV complications associated with CKD.
Main Methods:
- Review of experimental rodent models, human clinical trials, and meta-analyses.
- Analysis and comparison of properties of potential therapeutic interventions.
- Evaluation of diagnostic markers like the serum T50 assay.
Main Results:
- Experimental rodent models show promising therapeutic interventions that decrease CKD-induced calcification and prevent CV complications.
- The serum T50 assay indicates a link between serum calcification propensity and mortality in CKD patients.
- Current therapeutic options are limited, highlighting the need for new strategies.
Conclusions:
- Novel therapeutic interventions and diagnostic markers show potential for managing cardiovascular calcification in CKD.
- Further research and clinical trials are essential to translate these findings into effective clinical practice.
- Addressing CV calcification is critical for reducing CV risk and improving outcomes in CKD patients.
Abstract:
Patients with chronic kidney disease (CKD) are highly susceptible to cardiovascular (CV) complications, thus suffering from clinical manifestations such as heart failure and stroke. CV calcification greatly contributes to the increased CV risk in CKD patients. However, no clinically viable therapies towards treatment and prevention of CV calcification or early biomarkers have been approved to date, which is largely attributed to the asymptomatic progression of calcification and the dearth of high-resolution imaging techniques to detect early calcification prior to the 'point of no return'. Clearly, new intervention and management strategies are essential to reduce CV risk factors in CKD patients. In experimental rodent models, novel promising therapeutic interventions demonstrate decreased CKD-induced calcification and prevent CV complications. Potential diagnostic markers such as the serum T50 assay, which demonstrates an association of serum calcification propensity with all-cause mortality and CV death in CKD patients, have been developed. This review provides an overview of the latest observations and evaluates the potential of these new interventions in relation to CV calcification in CKD patients. To this end, potential therapeutics have been analyzed, and their properties compared via experimental rodent models, human clinical trials, and meta-analyses.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Urinary Tract Calculi IV: Nutrition Therapy and Prevention

